
Stem Cell Cure India Private Limited
Provides stem cell therapy, medical research, tourism, equipment sales, and health supplements for human health.
Provides stem cell therapy, medical research, tourism, equipment sales, and health supplements for human health.
Stem Cell Cure India Private Limited (SCCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2017 (Eight years 19 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tanu and Prashant Tyagi serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74999DL2017PTC316237
316237
Private Limited Indian Non-Government Company
18 Apr 2017
28 Aug 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tanu ![]() | Director | 01-Jun-2018 | Current |
Prashant Tyagi ![]() | Director | 18-Apr-2017 | Current |
Stem Cell Cure India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.98% increase. The company also saw a slight decrease in profitability, with a 6.25% decrease in profit. The company's net worth Soared by an impressive increase of 16.79%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Stem Cell Cure India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Prashant Tyagi is a mutual person
Tanu and Prashant Tyagi are mutual person
Tanu and Prashant Tyagi are mutual person
Tanu and Prashant Tyagi are mutual person
Tanu and Prashant Tyagi are mutual person
Prashant Tyagi is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Stem Cell Cure India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stem Cell Cure India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell Cure India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Stem Cell Cure India Private Limited last Annual general meeting of members was held on 28 Aug 2024 as per latest MCA records.
Stem Cell Cure India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Tanu was appointed as a Director was appointed as a Director on 01 Jun 2018 & has been associated with this company since 6 years 11 months .
Prashant Tyagi was appointed as a Director was appointed as a Director on 18 Apr 2017 & has been associated with this company since 8 years 19 days .
Stem Cell Cure India Private Limited was registered on 18 Apr 2017 with Roc Delhi & aged 8 years 19 days as per MCA records.
Stem Cell Cure India Private Limited was incorporated on 18 Apr 2017.
The authorized share capital of Stem Cell Cure India Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Stem Cell Cure India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Stem Cell Cure India Private Limited is H No. E-486 Gali No-9, West Vinod Nagar India, Delhi, 110092.
The corporate identification number (CIN) of Stem Cell Cure India Private Limited is U74999DL2017PTC316237 and the company number is 316237 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Stem Cell Cure India Private Limited has risen by 2.98%.
The financial reports for the fiscal year 2022 indicates that The net worth of Stem Cell Cure India Private Limited has experienced an upsurge of 16.79%.
The most recent Balance Sheet for Stem Cell Cure India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
NT